Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of hizentra®, a new 20% immunoglobulin preparation for subcutaneous administration, in pediatric patients with primary immunodeficiency.
Borte M, Pac M, Serban M, Gonzalez-Quevedo T, Grimbacher B, Jolles S, Zenker O, Neufang-Hueber J, Belohradsky B. Borte M, et al. Among authors: jolles s. J Clin Immunol. 2011 Oct;31(5):752-61. doi: 10.1007/s10875-011-9557-z. Epub 2011 Jun 15. J Clin Immunol. 2011. PMID: 21674136 Free PMC article. Clinical Trial.
Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
Jolles S, Bernatowska E, de Gracia J, Borte M, Cristea V, Peter HH, Belohradsky BH, Wahn V, Neufang-Hüber J, Zenker O, Grimbacher B. Jolles S, et al. Clin Immunol. 2011 Oct;141(1):90-102. doi: 10.1016/j.clim.2011.06.002. Epub 2011 Jun 12. Clin Immunol. 2011. PMID: 21705277 Free article. Clinical Trial.
Bioavailability of IgG administered by the subcutaneous route.
Berger M, Jolles S, Orange JS, Sleasman JW. Berger M, et al. Among authors: jolles s. J Clin Immunol. 2013 Jul;33(5):984-90. doi: 10.1007/s10875-013-9876-3. Epub 2013 Mar 1. J Clin Immunol. 2013. PMID: 23456255 Free PMC article.
The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012.
Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, Reiser V, Panahloo Z, Workman S, Slatter M, Gennery AR, Davies EG, Allwood Z, Arkwright PD, Helbert M, Longhurst HJ, Grigoriadou S, Devlin LA, Huissoon A, Krishna MT, Hackett S, Kumararatne DS, Condliffe AM, Baxendale H, Henderson K, Bethune C, Symons C, Wood P, Ford K, Patel S, Jain R, Jolles S, El-Shanawany T, Alachkar H, Herwadkar A, Sargur R, Shrimpton A, Hayman G, Abuzakouk M, Spickett G, Darroch CJ, Paulus S, Marshall SE, McDermott EM, Heath PT, Herriot R, Noorani S, Turner M, Khan S, Grimbacher B. Edgar JD, et al. Among authors: jolles s. Clin Exp Immunol. 2014 Jan;175(1):68-78. doi: 10.1111/cei.12172. Clin Exp Immunol. 2014. PMID: 23841717 Free PMC article. Clinical Trial.
New Frontiers in Subcutaneous Immunoglobulin Treatment.
Jolles S, Stein MR, Longhurst HJ, Borte M, Ritchie B, Sturzenegger MH, Berger M. Jolles S, et al. Biol Ther. 2011 Dec 14;1(1):3. doi: 10.1007/s13554-011-0009-3. eCollection 2011. Biol Ther. 2011. PMID: 24392293 Free PMC article. Review.
242 results